Back
Axsome Therapeutics Stock Price Chart

Mode Mobile Could be Next in Line
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
AXSM
Axsome Therapeutics
Last Price:
$104.43
Seasonality Move:
22.19%
7 Day Trial
ALL ACCESS PASS
$
7

This tech company grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing slight selling pressure.
Axsome Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 101.15 | Buy |
20-day SMA: | 109.42 | Sell |
50-day SMA: | 118.5 | Sell |
200-day SMA: | 97.31 | Buy |
8-day EMA: | 103.33 | Buy |
20-day EMA: | 107.82 | Sell |
50-day EMA: | 111.25 | Sell |
200-day EMA: | 99.58 | Buy |
Axsome Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.89 | Sell |
Relative Strength Index (14 RSI): | 41.94 | Sell |
Chaikin Money Flow: | -208623 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (101.48 - 123.54) | Sell |
Bollinger Bands (100): | (91.32 - 121.72) | Sell |
Axsome Therapeutics Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Axsome Therapeutics Stock
Is Axsome Therapeutics Stock a Buy?
-
Axsome Therapeutics share price is 104.46 while AXSM 8-day simple moving average is 101.15, which is a Buy signal.
-
The stock price of AXSM is 104.46 while Axsome Therapeutics 20-day SMA is 109.42, which makes it a Sell.
-
Axsome Therapeutics 50-day simple moving average is 118.50 while AXSM share price is 104.46, making it a Sell technically.
-
AXSM stock price is 104.46 and Axsome Therapeutics 200-day simple moving average is 97.31, creating a Buy signal.
AXSM Technical Analysis vs Fundamental Analysis
Sell
40
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy or a Sell?
-
Axsome Therapeutics stock is rated a SellThe current Axsome Therapeutics [AXSM] share price is $104.46. The Score for AXSM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Axsome Therapeutics Stock Info
Market Cap:
5.1B
Price in USD:
104.46
Share Volume:
486.8K
Axsome Therapeutics 52-Week Range
52-Week High:
139.13
52-Week Low:
64.11
Sell
40
Axsome Therapeutics (AXSM)
is a Sell
Axsome Therapeutics Share Price Forecast
-
What is the Axsome Therapeutics stock price today?The Axsome Therapeutics stock price is 104.46 USD today.
-
Will AXSM stock go up or go down?Axsome Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Axsome Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Axsome Therapeutics is overvalued.
Is Axsome Therapeutics Stock a Buy?
-
Axsome Therapeutics share price is 104.46 while AXSM 8-day exponential moving average is 103.33, which is a Buy signal.
-
The stock price of AXSM is 104.46 while Axsome Therapeutics 20-day EMA is 107.82, which makes it a Sell.
-
Axsome Therapeutics 50-day exponential moving average is 111.25 while AXSM share price is 104.46, making it a Sell technically.
-
AXSM stock price is 104.46 and Axsome Therapeutics 200-day simple moving average is 99.58, creating a Buy signal.
Fundamental Analysis of Axsome Therapeutics
Is Axsome Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.66 per share, an increase next quarter of $0.34 per share, an increase this year of $1.79 per share, and an increase next year of $4.87 per share.
Technical Analysis of Axsome Therapeutics
Should I short Axsome Therapeutics stock?
-
AXSM Moving Average Covergence Divergence (MACD) indicator is -4.89, suggesting Axsome Therapeutics is a Sell
-
Axsome Therapeutics Relative Strength Index (RSI) is 41.94, which suggest Axsome Therapeutics is oversold
-
The Bollinger Bands (25) for Axsome Therapeutics is (101.48 - 123.54), which suggest Axsome Therapeutics is a Sell
-
The Bollinger Bands (100) for Axsome Therapeutics is (91.32 - 121.72), which suggest Axsome Therapeutics is a Sell
* Axsome Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.